VCYT

NASDAQ 已收盘

Veracyte, Inc.

46.41 USD
-1.47+3.48%
盘后 45.30 +1.00%
2026-08-03
市值
$3.73B
市盈率
33.28
EPS
1.39
股息率
52 周区间
23.35 – 60.91
成交量
1.99M
Beta
1.94
目标价
58.91
52W 低 23.3552W 高 60.91
价格走势

公司简介

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its n...